Allotransplanted Neurons Used to Repair Peripheral Nerve Injury Do Not Elicit Overt Immunogenicity by Liu, Weimin et al.
Allotransplanted Neurons Used to Repair Peripheral
Nerve Injury Do Not Elicit Overt Immunogenicity
Weimin Liu
1,2, Yi Ren
1,2, Adam Bossert
1,2, Xiaowei Wang
1,2, Samantha Dayawansa
1,2, Jing Tong
1,2,3,
Xiaoshen He
4, Douglas H. Smith
5, Harris A. Gelbard
2,6, Jason H. Huang
1,2*
1Department of Neurosurgery, University of Rochester, Rochester, New York, United States of America, 2Center for Neural Development and Disease, University of
Rochester, Rochester, New York, United States of America, 3Department of Neurosurgery, Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei
Province, China, 4Department of Neurosurgery, Xijing Hospital, Fourth Military University, Xi’an, China, 5Center for Brain Injury and Repair, University of Pennsylvania,
Philadelphia, Pennsylvania, United States of America, 6Department of Neurology, University of Rochester, Rochester, New York, United States of America
Abstract
A major problem hindering the development of autograft alternatives for repairing peripheral nerve injuries is
immunogenicity. We have previously shown successful regeneration in transected rat sciatic nerves using conduits filled
with allogeneic dorsal root ganglion (DRG) cells without any immunosuppression. In this study, we re-examined the
immunogenicity of our DRG neuron implanted conduits as a potential strategy to overcome transplant rejection. A
biodegradable NeuraGenH tube was infused with pure DRG neurons or Schwann cells cultured from a rat strain differing
from the host rats and used to repair 8 mm gaps in the sciatic nerve. We observed enhanced regeneration with allogeneic
cells compared to empty conduits 16 weeks post-surgery, but morphological analyses suggest recovery comparable to the
healthy nerves was not achieved. The degree of regeneration was indistinguishable between DRG and Schwann cell
allografts although immunogenicity assessments revealed substantially increased presence of Interferon gamma (IFN-c)i n
Schwann cell allografts compared to the DRG allografts by two weeks post-surgery. Macrophage infiltration of the
regenerated nerve graft in the DRG group 16 weeks post-surgery was below the level of the empty conduit (0.56 fold
change from NG; p,0.05) while the Schwann cell group revealed significantly higher counts (1.29 fold change from NG;
p,0.001). Major histocompatibility complex I (MHC I) molecules were present in significantly increased levels in the DRG
and Schwann cell allograft groups compared to the hollow NG conduit and the Sham healthy nerve. Our results confirmed
previous studies that have reported Schwann cells as being immunogenic, likely due to MHC I expression. Nerve gap injuries
are difficult to repair; our data suggest that DRG neurons are superior medium to implant inside conduit tubes due to
reduced immunogenicity and represent a potential treatment strategy that could be preferable to the current gold standard
of autologous nerve transplant.
Citation: Liu W, Ren Y, Bossert A, Wang X, Dayawansa S, et al. (2012) Allotransplanted Neurons Used to Repair Peripheral Nerve Injury Do Not Elicit Overt
Immunogenicity. PLoS ONE 7(2): e31675. doi:10.1371/journal.pone.0031675
Editor: Colin Combs, University of North Dakota, United States of America
Received November 11, 2011; Accepted January 11, 2012; Published February 9, 2012
Copyright:  2012 Liu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by NIH grant R01-NS067435 and a SPAC grant from the University of Rochester Medical Center. The funders had no role in
study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Jason_Huang@URMC.Rochester.edu
Introduction
Each year approximately 360,000 people in the United States
suffer a peripheral nerve injury (PNI), which is a leading source of
lifelong disability [1]. The most frequent cause of PNIs is motor
vehicle accidents, while gunshot wounds, stabbings, and birth
trauma are also common factors. Patients suffering from
disabilities as a result of PNIs are also burdensome to the
healthcare system, with average hospital stays of 28 days each year
[1]. Currently, the most reliable choice in repair of major defects
in peripheral nerves is autologous nerve grafts [2]. The
introduction of an autologous axon segment provides a physical
and biological scaffolding to promote axonal outgrowth. Previous
work has shown that this technique appears to be the best option
for bridging axotomies in clinical situations [3]. The autograft
serves as a physical guide composed of morphologically native
biomaterial, which allows for the progression of ‘‘sprouting’’ axons
from the proximal end to the distal nerve stump. However, donor
autologous nerves are obviously limited in availability and
necessitate another surgical site with added potential for wound
morbidity. Accordingly, in recent years there has been consider-
able interest in developing alternative strategies to repair damaged
peripheral nerves through combinations of transplanted biological
or synthetic materials [4,5,6,7].
A combination approach of particular interest is using synthetic
tubes seeded with Schwann cells to direct axon regeneration
[4,8,9,10,11]. However, like most cells, Schwann cells express
major histocompatibility complex class I (MHC I), which occupy
the most gene-dense region of the mammalian genome and play
an important role in the immune system and autoimmunity. Thus,
there has been debate regarding the utility of allogeneic Schwann
cells for nerve repair due to their capacity to elicit host immune
attack. While the use of immunosuppressive therapy has been
proposed to reduce this immune response, it introduces compli-
cations of its own.
In contrast to Schwann cells, neurons represent one of the few
classes of cells that do not express MHC I. While there are
exceptions, such as neurons with MHC I expression in response to
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general may represent a relatively immune-privileged allogeneic
cell source. For example, neurons from DRGs have been isolated
from either fetal or adult animals and adult human organ donors,
and appear to survive well in culture and following transplanta-
tion, which makes them candidates in finding the biologic
alternative to autografts [15]. Indeed, we have recently demon-
strated consistent long-term survival of transplanted mechanically
elongated DRG neuron constructs despite the absence of
immunosuppressive therapy [16]. However, specific immune
response of the host animal was not evaluated.
In the present study, we assessed the immunogenicity of DRG
neuron nerve grafts compared to Schwann cell transplantation.
We repaired 8 mm sciatic nerve gaps using NeuraGenH nerve
guides (NG; Integra Lifesciences Corp, Plainsboro, NJ, USA)
seeded with either allogeneic DRG neurons or Schwann cells
transplanted from one strain of rat (Wistar) to another (Sprague
Dawley), and evaluated the regeneration of the sciatic nerve and
immune response using ELISA and immunohistochemistry (IHC).
Materials and Methods
DRG isolation
All animal experiments were approved by the University of
Rochester Animal Care Committee. The DRGs from C1 to L1
spinal segments of both sides were dissected from three-day-old
pups of the Wistar (Harlan, Charles River, Wilmington, MA) rat
strain after decapitated using standard techniques [16]. DRGs
were dissected aseptically and collected in ice cold Lebovitz’s L-15
non-CO2 sensitive balanced medium (Invitrogen, Carlsbad, CA).
DRG cell culture
After trimming of connective tissue, fat and nerve roots, the
DRGs were transferred into 0.1% collagenase (Sigma-Aldrich, St.
Louis, MO) in Neurobasal A media (Invitrogen, Carlsbad, CA)
and incubated for 0.5 hours at 37uC followed by a treatment in
fresh 0.1% collagenase for an additional 1 hour. Ganglia were
then gently washed twice in Ca-Mg-free Hank’s Balanced Salt
Solution (HBSS) (Invitrogen, Carlsbad, CA). The DRG pellets
were resuspended in complete medium and mechanically
separated using a fire polished pasture pipet until completely
dissociated and passed through a pre-wetted 70 um nylon cell
strainer (BD Falcon, Franklin Lakes, NJ). Cells were plated onto
either slides or dishes previously coated with 0.1 mg/ml poly-L-
lysine followed by 1.0 ug/ml laminin (Sigma-Aldrich, St. Louis,
MO) and maintained in complete growth medium consisting of
Neurobasal A Media supplemented with B27 (Invitrogen,
Carlsbad, CA), 1 mM L-Glutamine (Invitrogen, Carlsbad, CA),
0.1 mg/ml penicillin/streptomycin (Invitrogen, Carlsbad, CA),
and 50 ng/mL nerve growth factor 7S (Gibco Invitrogen,
Carlsbad, CA). The 4-well chamber slides (BD Falcon, Franklin
Lakes, NJ) were seeded at 5610
4 cells/well, the 35 mm dishes at
0.5610
6 cells/dish (Sigma-Aldrich, St. Louis, MO) and after cell
attachment, DRG cultures were immediately treated with mitotic
inhibitor cocktails consisting of 5 mM cytosine arabinoside, 20 mM
5-fluoro-29-deoxyuridine (Sigma-Aldrich, St. Louis, MO) and
20 mM uridine (Sigma-Aldrich, St. Louis, MO).
Schwann cell culture
Schwann cells were isolated using the same method as
described in DRG isolation. The ganglia were digested in
0.25% trypsin (Invitrogen, Carlsbad, CA)/0.03% collagenase in
HBSS and incubated three times at 37uC for 15 minutes. After
trypsin inhibition and mechanical dissociation, the cell suspension
was plated on poly-L-lysine and laminin-coated coverslips
(15 mm) at 4610
4 cells/coverslip or 35 mm dishes at 0.5610
6
cells/dish in Dulbecco’s Modified Eagle Medium/F12 (DMEM/
F12, Gibco Invitrogen, Carlsbad, CA) supplemented with 10%
fetal bovine serum (Sigma-Aldrich, St. Louis, MO), 1 mM L-
Glutamine, 0.1 mg/ml penicillin/streptomycin, 10 ng/mL nerve
growth factor 7S, and 1% N2 supplement (Invitrogen, Carlsbad,
CA). During the first 24 hours (i.e. days in vitro 1:DIV1), 1%
BSA (Sigma-Aldrich, St. Louis, MO) was added to the culture
medium.
Immunocytochemistry
After 1, 2, 3, 4 and 7 days of culturing, DRG or Schwann cells
plated on chamber slides were washed with phosphate saline
buffer (PBS), fixed with 4% paraformaldehyde in PBS for
30 minutes, and then rinsed with PBS. Cells were incubated
with blocking solution (5% normal donkey serum in PBS with
0.1% Triton X-100) for 1 hour at room temperature, followed by
4uC overnight incubation with the primary antibodies MAP-2
(Chicken polyclonal; 1:5000; Abcam, Cambridge, MA) and glial
fibrillary acidic protein (GFAP, Rabbit affinity isolated; 1:500;
Sigma-Aldrich, St. Louis, MO). The secondary antibodies Alexa
Fluor 488 goat anti-chicken (1:500, Invitrogen, Carlsbad, CA)
and Alexa Fluor 594 donkey anti-mouse (1:1000, Invitrogen,
Carlsbad, CA) were used to incubate cells for 2 hours at room
temperature in the dark, which was followed by PBS washing.
The slides were mounted with medium for fluorescence with
DAPI (Vector Lab, Burlingame, CA) and examined using an
Olympus Fluoview confocal microscope connected to a DP70
digital camera for bright phase, dark phase, and fluorescent
image acquisition.
Peripheral Nerve Injury (PNI) surgery and implantation of
allogeneic cells
Sciatic nerve injury was performed essentially as described by
Huang and Smith [16]. All procedures were approved by the
University of Rochester Animal Care Committee. Experimental
subjects were adult male Sprague-Dawley rats (Harlan, Charles
River, Wilmington, MA) (n=24). The animals were divided into
four groups: NeuraGenH nerve guide (NG; Integra Lifesciences
Corp, Plainsboro, NJ) seeded with Schwann cells from Wistar
rats (Wistar-Schwann, n=6); NeuraGenH nerve guide seeded
with DRG cells from Wistar rats (Wistar-DRG, n=6);
NeuraGenH nerve guide without cells (NG, n=6); and Sham-
operated control (Sham, n=6). After buprenorphine analgesia
and induction of anesthesia using Ketamine (100 mg/kg, I.P.), a
skin incision was made in the left hind limb from the proximal
region of the sciatic notch to the distal region of the popliteal
fossa. The gluteal muscle was dissected to expose the sciatic
nerve and its posterior tibial branch in order to excise an 8 mm
length of sciatic nerve above its trifurcation (Fig. 1A). The
NeuraGenH nerve guide tube (2.0 mm inside diameter
(ID)61.0 cm length) was used to provide a physical guide for
axons sprouting from the proximal nerve stump to the
disconnected distal nerve stump. For the animal groups receiving
DRGs or Schwann cells, 1.5610
6 cells in 20 uL sterile PBS were
placed in NG tubes using a syringe, making an allogeneic
transplant that was sutured to the epineurium using four 8–0
nylon sutures (Fig. 1B). After nerve repair, the muscle and skin
were closed with 6-0 vicry and 4-0 nylon sutures, respectively.
The incision was closed, and the wound site was disinfected with
Betadine (Purdue Products, Stamford, CT). Every two weeks,
blood samples were collected under anesthesia using Ketamine
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when the animals were sacrificed.
Enzyme-linked immunosorbent assay (ELISA)
Blood samples were collected from the tail vein 2, 4, 6, 8 and 16
weeks post-surgery. The cytokine levels in serum were measured
by ELISA assay using a commercially available interferon (IFN)-c
ELISA kit (Invitrogen, Carlsbad, CA), as per instruction of the
manufacturers.
Histology for the sciatic nerves
16 weeks after surgery, rats were anesthetized using Ketamine/
Xylazine and perfused intracardially using 16 PBS followed by
4% paraformaldehyde solution. Sciatic nerves were exposed and
harvested 10 mm proximal and distal to the coaptation sites of the
nerve guide constructs (Fig. 1C, D). Specimens were sequentially
fixed in 15% sucrose/4% PFA at 4uC overnight and then
dehydrated in 15% sucrose/1X PBS followed by 30% sucrose/1X
PBS. 10–30 um thick frozen sections from the specimen were
collected on a cryostat (Thermo Shandon Cryotome FSE
Cryostats, Fisher Scientific, Pittsburgh, PA). For each excised
nerve, axial slices were made beginning 2.0 mm from the proximal
and distal ends of the construct while longitudinal slices were made
along the length of the construct. Slices were stored at 280uC until
use for histology. Each specimen was examined at five sites
microscopically: nerve proximal (P) and distal (D) to the tube and
proximal (Lp), distal (Ld), and middle (Lm) regions inside the tube
(Fig. 1E).
Immunohistochemistry
After rinsing in PBS, sections were incubated with blocking
solution (5% normal donkey serum in PBS/0.1% Triton X-100)
for 1 hour at room temperature. Slides were incubated with
primary antibodies at 4uC overnight and with secondary
antibodies at room temperature for two hours in the dark; all
antibodies were diluted with 2% donkey serum in PBS/0.1%
Triton X-100. The primary antibodies used are: Chicken anti-
MAP2 (1:2000, Abcam, Cambridge, MA), Rabbit anti-MBP
(1:200, Chemicon, Billerica, MA), Rabbit anti-Laminin (1:1000,
Abcam, Cambridge, MA), Rabbit anti-NF-200 (1:250, Chemicon,
Billerica, MA), Mouse anti-ED1 (1:500, Abcam, Cambridge, MA),
and Mouse anti-MHC class I [OX-18] (1:200, Abcam, Cam-
bridge, MA).The secondary antibodies used are Alexa Fluor 488
Donkey anti-Chicken (1:500, Invitrogen, Carlsbad, CA), Alexa
Fluor 594 Donkey anti-Rabbit (1:1000, Invitrogen, Carlsbad, CA),
Alexa Fluor 488 Donkey anti-Rabbit (1:1000, Invitrogen,
Carlsbad, CA), and Alexa Fluor 594 Donkey anti-Mouse
(1:1000, Invitrogen, Carlsbad, CA). Slides were rinsed with PBS
after each incubation, mounted with Medium for Fluorescence
with DAPI (Vector Lab, Burlingame, CA), and examined under a
BX41 Olympus Fluoview confocal microscope connected to a
DP70 digital camera.
Figure 1. Surgical Procedures. (A) After skin incision, an 8 mm length of sciatic nerve was excised. (B) A NeuraGenH nerve guide tube of 2.0 mm
ID61.0 cm length was used to provide a physical guide for axons sprouting from the proximal nerve stump to reach the disconnected nerve
segment. (C) The rats were sacrificed at 16 weeks post-PNI and sciatic nerves were harvested by excising 1.0 cm outside the NG tube. (D) The tube
(top) is distinguishable from the contralateral healthy tissue (bottom) as an enlarged section of the nerve. The contralateral nerve served as a control
for each rat. (E) For histological analysis, frozen sections were cut and examined at five locations: nerve proximal (P) and distal (D) to the tube and
proximal (Lp), distal (Ld), and middle (Lm) longitudinal regions inside the tube.
doi:10.1371/journal.pone.0031675.g001
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All quantitative immune response analyses of ELISA, ED1
immunoreactive macrophage and axon density data are expressed
as mean 6 the standard error of the mean (SEM). All statistical
tests used Prism software (GraphPad, San Diego, CA). P values
,0.05 were considered significant. For the ELISA data,
experimental points represent triplicates with a minimum of 5–6
animals per group. Statistical comparisons were made between
different experimental groups using one-way repeated measures
analysis of variance test (ANOVA), followed by Bonferroni’s
Multiple Comparison Test. The macrophages were counted from
206images of 10 um tissue sections. Each 0.15 mm
2 area at five
different locations (P, D, Lp, Lm, Ld; Fig. 1E) that were identical
for each slide was counted three times per rat. Three rats from
each experimental group were randomly chosen for ED1
immunoreactive macrophage. NF-200 expression served to
identify axonal regeneration by quantifying axon density. Three
rats from each experimental group were randomly chosen for the
axon density count. The density of axons was counted from 406
images of 10 um distal tissue sections. Each slide was counted four
times per rat. The sum of distal axonal density 16 weeks after PNI
was calculated for each rat and was expressed as standard optical
density (SOD) to generate an estimate of the total number of
regenerated axons in the sciatic nerve. Counts were performed
using Image-Pro Plus 6.0 software (Media Cybernetics, Bethesda,
MD). One-way ANOVA test was used to determine significant
differences in macrophage and axon density count followed by
Tukey and Bonferroni multiple comparison post tests.
Results
Evaluating the health of cultured neurons as
implantation to repair the peripheral nerve injury
To identify and assess the health of DRGs and Schwann cells,
cultured cells were labeled with MAP2, a marker widely used to
characterize neurons including DRGs, and with GFAP, a marker
for Schwann cells. By DIV1, the DRG cells were firmly attached
to the previously plated and extended neurites. DRG neurons
were easily distinguished from Schwann cells by their distinctly
larger diameter, phase-bright soma, and finer processes. At the
end of the treatment with antimitotic agents (DIV3 and 4), the
DRG cells had extended axons and the non-neuronal cells had
essentially disappeared (Fig. 2A). By DIV2 and 3, Schwann cells
showed healthy elongated shapes and dipolar morphologies
(Fig. 2B). Based on these results, DRG or Schwann cells were
injected into NG tubes and grafted into the animal groups
receiving cells on culture DIV3–4 and 2–3, respectively.
Recipient survival rate
All animals recovered well from the initial surgery for the
duration of the 16 week in vivo study without signs of infection or
immunorejection even though no immunosuppressive therapies
were given. However, two animals (one from the Sham group, one
from the Wistar-DRG group) died under general anaesthesia
during blood sample collection and were therefore excluded from
this study.
Histological analysis of sciatic nerve regeneration
16 weeks post-surgery, sciatic nerves were harvested and
examined using histological methods. To examine the pattern of
myelination of regenerated axons, we used MAP2 as a neuronal
marker and MBP as a myelin maker. MAP2/MBP immunohis-
tochemistry (Fig. 3A) demonstrated that the proximal and distal
nerve stumps of the control animals exhibited axons surrounded
by tightly packed and evenly distributed myelin rings. Throughout
the inside of the conduit tube, the healthy Sham control group
shows a wave pattern of axons and myelin. Individual axons were
also myelinated when the transection was repaired using a hollow
NG tube. However, the NG group exhibited significantly less
myelin expression at the proximal stump compared to the Sham
group while the axons appear in aggregates and myelin rings are
more variable in size at the distal stump. The reduction in the
number of axons in the NG group compared to the Sham group is
also evident in the longitudinal sections, which show disconnected
axons growing in random directions. The Wistar-DRG group
exhibited similar structure and myelin distribution as the Sham
group at the proximal stump, but loses the ring pattern at the distal
stump such that many axons appear to be only partially
myelinated. Myelination is enhanced within the conduit tube in
the Wistar-DRG group and although both regions still appear
disconnected, the middle region demonstrated the best connec-
tivity and axon number compared to the distal region. The Wistar-
Schwann group consisted of fewer and larger diameter myelin
rings at the proximal stump compared to the control Sham group
and significantly fewer and less distinct axons at both the proximal
and distal stumps compared to all three groups. Similar to the
Figure 2. Evaluating the health of cultured neurons. (A) At the end of antimitotic treatment (day 3 and 4), the DRG cells (MAP-2
immunopositive neurons; green) had extended axons, and non-neuronal cells were essentially nonexistent. (B) Schwann cells demonstrated strong
GFAP (red) expression and an elongated shape and dipolar morphology at day 2 and 3. 206, Scale bar: 50 um. DAPI (blue).
doi:10.1371/journal.pone.0031675.g002
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Wistar-Schwann group appears fragmented but still surrounds the
axons and has superior myelination compared to the empty NG
tube. However, axons at the middle region of the tube, although
more dense, appear as short strands growing in inconsistent
directions. The distal site of the tube in the Wistar-Schwann group
seems to recover the morphology most similar to that of the Sham
despite more abundant axons. These observations suggested that
DRG and Schwann cell-infused NG tubes are capable of
enhancing myelination of regenerated axons, although recovery
of the morphology comparable to a healthy sciatic nerve was not
achieved within 16 weeks post-surgery.
Because laminin is a constituent of Schwann cell basal lamina
and is known to be essential for Schwann cell differentiation and
axon myelination [17], we also confirmed the myelination results
with laminin immunohistochemistry (Fig. 3B). Similar to MBP
expression, the Sham group shows a ring-patterned structure at
the proximal and distal stumps and wave pattern inside the tube.
The proximal and distal stumps for the NG groups were similar in
appearance to the Sham. However, the mid-section of the tube
revealed few thick and disconnected tube-like structures. Wistar-
DRG group showed a pattern similar to the control at the
proximal stump but rings of smaller diameter that are variable in
size at the distal stump. Longitudinal sections revealed bundles of
elongated parallel fibers, some of which appear disconnected.
Wistar-Schwann group also shows healthy appearance at the
proximal stump. The distal stump, however, retains very few
distinguishable ring-like structures. In contrast, the mid-section of
the tube has mostly recovered the appearance of a healthy nerve,
although laminin expression was significantly more abundant
compared to the Sham. Thus, the pattern of laminin was
consistent with the previously observed pattern of myelination
from MAP2/MBP IHC.
We next examined the immunohistochemical expression of
neurofilament heavy intermediate filament protein (NF-200) and
microphage infiltration using an antibody to the lysosomal
membrane glycoprotein ED1 (Fig. 4), which is predominantly
expressed in cells of mononuclear/macrophage lineage, and index
of MHC I immunoreactivity in the regenerated sciatic nerve
(Fig. 5A). NF-200 expression also served to identify axon
morphology independent of myelination. Sham group exhibited
evenly distributed axons at all sites inspected. The axon diameter
seemed to be more variable in size in the distal stump compared to
the proximal. Longitudinal sections revealed elongated fibers. The
hollow NG graft significantly reduced the number of axons in the
longitudinal sections, which appear as short strands rather than
elongated fibers. Axons within the proximal stump were dispersed
but not as evenly distributed as in a healthy nerve. The distal
stump appeared to contain less axons compared to the Sham. The
axon morphology at the proximal stump of the Wistar-DRG
group appeared to resemble the Sham. However, axons in the
distal stump were more abundant compared to the NG group but
reduced in diameter compared to the Sham. Differences were
observed among the three sites examined inside the tube: the
proximal region contained elongated fibers and appeared healthy;
middle region lacked elongated fibers but showed few aggregates
of axons; and the distal region appeared to contain a mixture of
aggregates and elongated fibers. Similarly, the Wistar-Schwann
group exhibited a healthy morphology at the proximal region,
aggregated of axons in the middle, and even fewer elongated fibers
at the distal region within the tube. The proximal stump of the
Wistar-Schwann group contained axons of larger diameter but
uneven distribution. The distal stump appeared similar to the
Wistar-DRG group. Thus, the distal stumps of all repaired nerves
shared a similar pathological appearance while recovery of axon
morphology at the proximal stump and inside the nerve guide was
enhanced in Wistar-DRG and Wistar-Schwann groups.
To quantitatively assess axon regeneration, we counted the
density of axons in the distal stump expressing NF-200 and
compared among the groups (Fig. 5B). Compared to the Sham
group, the NG group had significantly fewer axons at the distal
stump, suggesting limited regeneration following the injury. In
contrast, the Wistar-DRG and Wistar-Schwann groups did not
significantly differ in axon density from the Sham group,
indicating that the number of axons has almost recovered to
similar levels as the healthy nerves in the Sham group. Although
axon density in the DRG and Schwann allograft groups were not
significantly higher than that of the NG group, the presence of
DRG neurons and Schwann cells is correlated with an increasing
trend in axon density and regeneration.
Acute rejection assessment by serum levels of IFN-c,
quantification of macrophages, and immunoreactivity of
MHC I
Serum level of IFN-c was determined by ELISA in all
experimental groups 2, 4, 6, 8 and 16 weeks post-surgery. The
IFN-c level in the Wistar-Schwann group was higher than the
Sham group 2 weeks after surgery (P,0.01). For the NG and
Wistar-DRG groups, IFN-c serum concentrations were not
significantly different compared with the Sham control levels at
all time points following PNI surgery (Fig. 6).
Anti-ED1 immunohistochemistry was used to determine
macrophage count for each experimental group. The ANOVA
test performed on macrophage count per group yielded strong
evidence (P,0.0001) that the mean macrophage count for all
experimental groups is significantly different. Both Bonferroni and
Tukey multiple comparison post tests found the same significant
differences between all groups (Fig. 4B). All operated groups had
significantly elevated macrophage count from the Sham control
group. The Wistar-DRG group was significant at the p,0.01
significance level whereas the Wistar-Schwann group was
significant at the p,0.001 level. In addition, the Wistar-Schwann
group was significantly elevated compared to the Wistar-DRG
group at the p,0.001 level. These statistically significant findings
can be visually confirmed using the immunohistochemistry data
(Fig. 4A).
Major histocompatibility complex class I molecules (MHC I) are
believed to be involved with direct allograft recognition and
rejection by the host. These molecules are upregulated in response
to injury [12] and are another measurement of immunogenicity
and the host response to the varying material seeded within the
nerve guides. Both the Wistar-Schwann and Wistar-DRG groups
showed much higher MHC I expression when compared to the
Sham and NG control groups (Fig. 5A). The pattern of MHC I
expression coincided with that of laminin and MBP, primarily
residing around rather than within the nerve fascicles. Compared
Figure 3. Histological analysis of the sciatic nerve 16 weeks post-PNI. For anatomical terminology, refer to Fig. 1E. (A) Myelination (MBP,
green) of the regenerated axons (MAP2, red). Inset show the structure of individual myelinated axon fascicles, enlarged from 406 image. Axial
sections 406, longitudinal sections 206. Thickness=15 um. (B) Expression of laminin (green) was consistent with results from Fig. 3A. DAPI (blue),
206. Thickness=15 um.
doi:10.1371/journal.pone.0031675.g003
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expression more confined to the region within the tube and at
reduced levels at the proximal and distal stumps.
Discussion
Many studies have attempted to repair PNIs using tissue
engineered nerve conduits. Conduits have been seeded with
various supporting cell types, secreted factors, and extracellular
matrix proteins to assist their mechanical guidance [15]. Although
cellular grafts have been shown to enhance regeneration
compared to acellular grafts, a major problem is the host immune
response associated with the cellular components [18]. Schwann
cells are one of the supporting cell types that have received much
attention for their potential to enhance regeneration of injured
peripheral nerves [4,8,9,10,18]. Attempts have been made to
overcome immunogenicity by using syngeneic Schwann cells [8],
but this method is limited by the availability of compatible donors
and may not improve morphological recovery above the capacity
an acellular guide offers [4]. In this study, we were able to
demonstrate successful regeneration of the transected sciatic nerve
using nerve guides seeded with allogeneic DRG neurons and
Schwann cells in the absence of immunosuppressant therapy.
By measuring IFN-c, a pro-inflammatory cytokine, and
macrophage count in our repaired nerve lesions, we are able to
estimate the magnitude of the immune response that occurred in
our experimental paradigms. Macrophages are key antigen
presenting cells and recognize the MHC I molecules on foreign
cells within the allograft. The macrophages then internalize the
foreign cells, expose foreign antigen on their surface, and therefore
help activate T helper (Th) cells which recruit stronger immune
responses [19]. The Th cells secrete cytokines, such as IFN-c,
which is the most potent inducer of MHC I molecules and is also
upregulated in the central nervous system (CNS) after traumatic
injury [13,20]. It is also present at elevated levels during the course
of autoimmune diseases, such as multiple sclerosis, and in chronic
neurodegenerative diseases [21].
In addition, Th cells can be regulated by IFN-c. Expression of
IFN-c was found to regulate Th1 (activated) and Th2 (inactivated)
expression by inhibiting Th2 [22]. Th1 response is associated with
transplant rejection, while a Th2 response may contribute to
tolerance and stable graft survival [23]. Therefore, as more Th
cells are activated by macrophages, more Th1 cells are formed,
which release IFN-c, which propagates the immunorejection
cascade. This process involving increased IFN-c levels during
rejection was also observed in heart and kidney transplants [24]. It
is reported that Th1 polarization is related to the acute rejection in
allograft transplants. Other cytokines including IL-2, IL-10, and
INF-c, can all accelerate T-cell mediated immune response while
IL-4, 5, and 6 are helpful for B-cell mediated humoral immunity.
Therefore, increases in IFN-c during the course of our experiment
can be correlated with immunorejection of the implanted conduit
tubes.
The ELISA analyses demonstrated that heightened acute
immune system activity was only observed in the Wistar-Schwann
group. There were statistically significant increases in IFN-c level
by two weeks post-surgery for this group, likely corresponding to
the end of the acute phase of PNI. Thus, allogeneic supporting
Schwann cells seem to induce the upregulation of inflammatory
cytokines such as IFN-c, which are known to participate in
immunorejection. This significant difference in upregulation was
evident even at two weeks post-surgery, raising the possibility that
more severe immune response could have taken place at earlier
time points after PNI. In addition, the lack of significant
differences at later time points may be because the assay was
performed using plasma rather than tissue samples, which could
have diluted the localized changes at the injury site. Thus,
confirming the significance of IFN-c upregulation by Schwann
and other cell types may require further analysis at earlier time
points after surgery by directly examining tissue samples near the
injury site.
The ED1 immunoreactive cell count is another measurement of
how the rats’ immune systems responded to the interventions
associated with each experimental group during long-term
recovery. Since IFN-c is important in recruiting macrophages
[25] we would expect increased macrophage count where we
observed increased IFN-c levels in our ELISA analysis. We
observed this pattern to a much greater degree than expected,
having significant differences in all pairings of the experimental
groups even at 16 weeks post-surgery, long after when the
maximal immune response would have occurred. Next to the
Sham control group, the Wistar-DRG group had the lowest
macrophage count whereas the Wistar-Schwann group had the
highest. These results were consistent with our IFN-c findings that,
there were significant differences that are suggestive of immunor-
ejection long past the acute phase, further indicating that there
may be intrinsic differences in the potential of DRG neurons and
Schwann cells to elicit immune responses. We hypothesize that this
observation is due to more abundant MHC I molecule presence in
the Schwann cell allografts and reduced presence in the DRG cell
allografts. In 1915, when allograft rejection was first suggested to
be the result of test subject immune system response, the biologic
mechanism was unknown [19]. It is now agreed upon that
immunorejection occurs because allografts are foreign to the host.
The idea that MHC antigen expressing cells, such as Schwann
cells, are the immunogenic components that cause this conduit
rejection has been proposed before [26]. We are also attributing
our results to the acute immune response involved with MHC
antigens and the resulting lymphocyte immune response described
by Pattison et al [27].
MHC I expression and regulation is crucial for the immune
response process, nerve regeneration, and functional recovery.
Currently, MHC I molecules are believed to be involved with
direct allograft recognition and rejection by the host. These
molecules help direct the immune response by detecting
unrecognized peptide sequences on foreign cells. This has been
determined to be the case both in humans and other vertebrate
animals [28]. MHC I molecules are vigorously upregulated
immediately after peripheral axotomy when foreign cells are
present and microglia are activated. Therefore, drastic nerve
repair differences can result if MHC I levels vary among our
experimental groups. MHC I mRNA have been shown to be
constitutively expressed in peripheral motor neurons [13]. In
Figure 4. Histological and quantitative analyses of macrophage presence. For anatomical terminology, refer to Fig. 1E. (A) ED1 IHC shows
macrophage (red) location and number in each group in neuronal structure (NF-200, green). Note Sham, Wistar-DRG, NG, and Wistar Schwann
represent macrophage presence in increasing order in all tissue sections. DAPI (blue), 206. Thickness=15 um. (B) Quantification and statistical
analysis of ED1 immunoreactive cells. Macrophage count reflects immunohistochemistry microscopy analysis in Fig. 4A. ANOVA Bonferroni and Tukey
multiple comparison post tests determined significant differences in the mean macrophage count in each group: *P,0.05; **P,0.01; ***P,0.001.
Both post tests found the same results. Error bars represent 6 standard error of the mean.
doi:10.1371/journal.pone.0031675.g004
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PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e31675Figure 5. MHC I immunoreactivity (red) in neuronal structure (NF-200, green). For anatomical terminology, refer to Fig. 1E. (A) Increased
MHC I immunoreactivity were observed in NG, DRG, and Schwann groups compared to the Sham group. DAPI (blue), 206. Thickness=15 um. (B)
Axon regeneration estimated by NF-200 expressing axons. Axon density in distal stump was calculated and expressed as standard optical density
(SOD) for each group. n=3, 406image of 10 um sections.
doi:10.1371/journal.pone.0031675.g005
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and upregulated in the sciatic nerve following axotomy [12,14].
We also demonstrated increased MHC I in all of our operated
experimental groups compared to the healthy control (Fig. 5A).
Besides mediating immune response, MHC I also appears to play
an important role in nerve regeneration. In axotomized rat facial
nerve, the expression of MHC I and II was detectable in the motor
neurons 2–4 days post-operation [20]. The expression subsided
after 12–18 days in crushed nerves, when the nerve had
reinnervated the target muscle, but remained elevated in
transected nerves. These observations demonstrate a correlation
between MHC I expression and the degree of regeneration, which
suggests that the relatively reduced level of MHC I in our Wistar-
DRG group may represent a more advanced stage of recovery.
Additionally, mice with genetically enhanced neuronal MHC I
expression exhibited improved recovery of locomotor functions
following spinal cord injury compared to wild-type mice [29]. In
contrast, mice deficient in MHC I expression exhibited abnormal
organization of the neuromuscular junction following regeneration
and delayed motor function recovery [14]. This was attributed to
impaired interaction between the axons and Schwann cells,
resulting in inappropriate regulation of synapse formation. This
shows that MHC immunoreactivity seems to have beneficial
effects on promoting and sustaining axonal regeneration. Conse-
quently, MHC I incompatibility between the allogeneic Schwann
cells and the regenerating axons in the host rat in our experiments
could have deleterious effects on regeneration of the sciatic nerve
in addition to the inflammatory response.
A previous study comparing syngeneic and allogeneic Schwann
cell transplantation revealed that allogeneic Schwann cells were
rejected by 6 weeks and that the levels of MHC I and II expression
increased between 2 and 3 weeks post-operation when using
allogeneic Schwann cells whereas the levels decreased when
syngeneic Schwann cells were used [11]. Thus, even if no
significant differences in regenerative capacity could be identified,
the use of Schwann cells to repair peripheral nerve lesions remains
challenging due to its immunogenicity effects.
In contrast, DRG neurons possess unique immunological
properties. The CNS is found to express reduced levels of MHC
antigens and only expresses MHC II after injury whereas MHC I
and II are expressed constitutively in the PNS [30]. These
differences are likely the underlying reason for the immune-
privileged state of the CNS and the differential response of the
CNS and PNS to nerve injury, such as more rapid elimination of
activated T cells in the CNS. While some studies have reported
untreated embryonic DRG neurons to express MHC I in vitro [31],
many in vivo studies suggest that the expression level is undetectable
in healthy tissue and the upregulation following injury is primarily
due to surrounding non-neural cell types [11].
While it is more likely that reduced DRG MHC I expression or
host MHC I compatibility privileged the Wistar-DRG group with
less immunogenicity, it is also possible that the implanted DRG cells
Figure 6. ELISA assays of IFN-c in serum 2, 4, 6, 8 and 16 weeks post-surgery, respectively. IFN-c levels of the allograft Wistar-Schwann
group was higher than the Sham group in serum 2 weeks after surgery (P,0.01). For the NG and Wistar-DRG groups, IFN-c concentrations in serum
were not significantly different compared with that in sham control at all time points following PNI surgery. All measurements were done in
triplicates. Data are representative of using n=5, 6, 6, 5 mice in Sham, NG, Wistar-Schwann and Wistar-DRG groups, respectively.
doi:10.1371/journal.pone.0031675.g006
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from eliciting a strong immune response. Studies have shown that
biodegradable materials that the body absorbs more slowly elicit less
foreign body immune response involving macrophages [5]. This
was a proposed reason for immunogenic response differences
observed among conduit tubes in Ghazanvi et al [6].
Previous studies have shown that allogeneic grafted tissue may
elicit up to ten-times more immune response and MHC expression
compared to autografts [32]. Our study used biodegradable,
synthetic conduit tubes with allografted cells and demonstrated a
reduced immune response in our DRG allografts compared to
both the Wistar-Schwann and empty NG groups, suggesting that
DRG allografts are capable of reducing the immune response
compared to acellular conduits. Whether this reduction in immune
response by using DRG allografts can achieve the same levels as
autologous or syngeneic grafts will be the aim of our next study. In
contrast, conduits filled with Wistar-Schwann cells exhibited high
immune activity. This is expected because Schwann cells are
credited as being the main antigen expressing immunogenic entity
in nerve allografts [26].
Compared to the Wistar-Schwann group, the empty NG group
was found to have less immunorejection, but axon regeneration
was compromised. This tradeoff makes it difficult to determine
which is a better repair method in the long run. Wistar-DRG
appears to trump both problems by having a low immune
response in addition to superior regeneration capabilities com-
pared to the empty NG tube.
BothSchwannand DRG cells seemed toaffectthe morphology of
the regenerating axon and the pattern of myelination at different
sites within the injured nerve. A previous study has thoroughly
examined the process of nerve regeneration in the rat up to 21
months post implantation and revealed that elongation and
branching of axonal sprouts takes place within weeks while increases
in the regenerated axon diameter only occurs several months after
the repair [33]. This temporal dissociation is an efficient mechanism
to prevent degeneration of the distal stump by ensuring initial
reinnervationandsubsequentlyrefining theappropriateconnections
by eliminating extraneous axon sprouts. Thus, the differences in
axon number observed in our IHC results may represent different
stages of regeneration. The more abundant axons in the Wistar-
Schwann group may reflect an earlier stage of regeneration during
axonal sprouting while the Wistar-DRG group may haveprogressed
toalaterstageatwhichaxonalrefinementhasoccurred.Inaddition,
the morphologic assessments may represent a mixed population of
mature, immature, and degenerating axons since degeneration of
regenerated axons and secondary demyelination may occur
following nerve graft implantation [7], and the surviving axons
may not have completely matured at 16 weeks post implantation.
Thus, conclusive differences in morphologic recovery between the
Wistar-DRG and Wistar-Schwann groups could not be observed
using IHC and microscopy methods. Quantitative difference in
axon regeneration was also not found by counting the density of
axons at the distal stump of each group. These results suggest that,
although DRG and Schwann cell transplantation may be more
preferable forpotentiating axonregeneration compared toanempty
conduit, no significant difference in superior axon regeneration was
found between the Wistar-DRG and Wistar-Schwann groups.
Furthermore, peripheral nerve regeneration is an interdependent
process that requires interaction between axons and Schwann cells.
While mature Schwann cells can survive in the absence of neurons,
nerve injury can trigger de-differentiation into immature cells [10].
The immature cell type proliferates and, if remain deinnervated for
an extend period of time, will not survive. Conversely, the nerve
stumpthatresults fromnerve injuryrequiresvariousfactorsreleased
by Schwann cells in order to guide their growth [10]. Thus, an
imbalance between the DRG and Schwann cells due to transplan-
tation of exogenous cells may interfere with effective signaling
between the two cell types and may not significantly enhance nerve
regeneration. Indeed, Inhibitory effects of Schwann cells have been
previously reported when seeded onto nerve guide grafts in similar
attempts to repair transected rat sciatic nerves, including reduction
in the number and diameter of regenerated axons and the
proportion of myelinated axons [9].
Although many studies have considered Schwann cell transplan-
tation as means to repair injured peripheral nerves due to its various
roles in enhancing axonal growth, DRG cell implantation may be
an equally reasonable option due to its mitogenic effects on
Schwann cells [17]. In fact, implantation of DRG neurons may be
more desirable because they can stimulate the proliferation and
migration of endogenous Schwann cells and accelerate axon growth
without the concern of immunogenicity. DRG and Schwann cells
both have the potential to enhance axon regeneration, but may act
through different mechanisms, which likely resulted in the minor
morphological differences observed between the Wistar-DRG and
Wistar-Schwann groups. Furthermore, the axons from the
transplanted DRG neurons, which are lacking in Schwann cells,
could also havecontributed to improved regeneration inthe Wistar-
DRG group. Satellite cells are also likely to be present in the DRG
neuron cultures, which could secrete tropic factors or other
molecules and affect neurite outgrowth. Whether these contribu-
tions are significant for morphological and functional recovery will
be examined in future studies.
Our results suggest that Schwann cell-mediated immunity may
be associated with, and a part of, the transplant rejection response,
while pure DRG neurons may contribute to tolerance and stable
graft survival. In comparison to Schwann cells, conduit tubes
infused with cultured allogeneic DRG cells present a promising
alternative method for repairing nerve gaps in injured peripheral
nerves by substantially reducing the possibility of rejection without
compromising regenerative capabilities. By successfully finding a
method that reduces the host immuneresponsetoforeignimplanted
cells during nerve repair, our study helps to establish a promising
future for allografted conduit nerve repair that could be applied to
long nerve lesions. While the functional motor and sensory recovery
using this method needsto be verifiedinfuturestudies, replacing the
current ‘‘gold standard’’ of repairing nerve lesions using autografts
with nerve guides that do not sacrifice healthy motor or sensory
functions is becoming more of a reality each day.
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